Deerfield Management Company, L.P. (Series C) has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $4.84 Billion distributed in 367 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $1.5B, Viatris Inc with a value of $255M, Centene Corp with a value of $187M, Larimar Therapeutics, Inc. with a value of $161M, and Adapt Health Corp. with a value of $153M.

Examining the 13F form we can see an increase of $777M in the current position value, from $4.06B to 4.84B.

Deerfield Management Company, L.P. (Series C) is based out at New York, NY

Below you can find more details about Deerfield Management Company, L.P. (Series C) portfolio as well as his latest detailed transactions.

Portfolio value $4.84 Billion
Healthcare: $4.76 Billion
Technology: $18.1 Million
Consumer Cyclical: $15.1 Million
Financial Services: $13.6 Million
Industrials: $13.3 Million
Consumer Defensive: $5 Million
Communication Services: $3.68 Million
Energy: $3.05 Million
Other: $5.73 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 367
  • Current Value $4.84 Billion
  • Prior Value $4.06 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 226 stocks
  • Additional Purchases 65 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 45 stocks
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.